FEIM's H1 FY24 revenues rose by 51.4% compared to H1 FY23, driven by increased revenues from government satellite programs and non-space DOD customers. The company reported a net income of $2.8 ...
Shares of Frequency Therapeutics FREQ surged 77.48% on Friday, after management announced that the company entered into a definitive agreement with RNA editing company, Korro Bio, to merge in an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback